According to the report “Protein A Resin Market” published by Market Data Forecast, the global market is projected to reach USD 575.62 million by 2021, at a CAGR of 8.2% from 2016 to 2021.
For full report refer at http://www.marketdataforecast.com/market-reports/global-protein-a-resins-market-379/
Monoclonal antibodies can be defined as an antibody produced by a single clone of cells; they antibodies can be produced in large quantities in the laboratory. They can be used to carry drugs, toxins, or radioactive substances straight to cancer cells. Increasing research on monoclonal antibodies is expected to drive the sales of Protein A resins during the forecast period. Demand for Protein A resin is continuously rising among chromatography resins
Free sample for the report is available at http://www.marketdataforecast.com/market-reports/global-protein-a-resins-market-379/request-sample
Growing demand for biosimilars and increasing investments in the development of biosimilar products are the major factors driving the market for monoclonal antibodies. However increasing awareness about alternate methods to purify monoclonal antibodies is expected to hamper the Protein A Resins market. High cost of the Protein A resin is also a major factor hindering the growth of the market.
Request customization at http://www.marketdataforecast.com/market-reports/global-protein-a-resins-market-379/customize-report
Global Protein A Resin Market is segmented as:
1) By Product
•Natural Protein A Resin,
•Recombinant Protein A Resin
2) By Application
3) By Matrix Type
•Glass or Silica,
4) By End User
•Clinical Research Laboratories and
5) By Geography
•Middle-East & Africa
Inquire more about the report at http://www.marketdataforecast.com/market-reports/global-protein-a-resins-market-379/inquire
Some of the key companies covered in the report are GE Healthcare, Repligen Corporation, Novasep, Tosoh Bioscience, GenScript, Thermo Fisher Scientific, EMD Millipore and Expedeon Ltd.
Buy now at https://www.marketdataforecast.com/cart/buy-now/global-protein-a-resins-market-379